Greel Medicines Expenditures

The Novartis affair has evolved into a major issue involving an institutional aberration and a departure from democratic normalcy. It emerged as a result of audits of the multi-national Swiss pharmaceuticals company by US authorities, which are sensitive about issues of exceedingly rapid entrepreneurial growth and of competition. Needless to say, Novartis over recent years […]